Recipharm and Adroit Science collaborate and expand service offering
Solid-state characterisation services will enhance complete molecule-to-product development capability
Recipharm and Adroit Science have formed a new strategic collaboration. Adroit Science will support Recipharm’s pharmaceutical development with high quality solid-state characterisation services.
By combining expertise in formulation development, API development, chemical analysis and solid-state characterisation, both the speed and cost of development can be reduced while, at the same time, improving quality.
‘I am very excited about this collaboration,’ says Carl-Johan Spak, Executive Vice President, Development and Technology at Recipharm, adding: ‘With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way.
‘Adroit Science has established itself as one of the leading providers of solid-state characterisation services in Northern Europe, enabling us to offer an even better service to our customers, including complete development from molecule to product.’
'Adroit Science and Recipharm have already co-operated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship. We are delighted to join forces with a leading CDMO like Recipharm and predict that this will bring new opportunities in worldwide customer support,’ remarked Hans Gredeby, CEO of Adroit Science.
